ProCE Banner Activity

Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches

Slideset Download

Learn about the latest updates to risk stratification and novel therapies for myelodysplastic syndromes including ways to assess risk, treatment selection, and ongoing clinical trials of novel therapies.

Released: January 27, 2023

Expiration: January 26, 2024

No longer available for credit.
Begin Activity

Share

Faculty

Sara Tinsley-Vance

Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Smart Patients

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and Karyopharm Therapeutics Inc.

Gilead Sciences, Inc.

Karyopharm Therapeutics Inc.

Partners

Smart Patients

ProCE Banner